Loading…

Human immune cell engraftment does not alter development of severe acute Rift Valley fever in mice

Rift Valley fever (RVF) in humans is usually mild, but, in a subset of cases, can progress to severe hepatic and neurological disease. Rodent models of RVF generally develop acute severe clinical disease. Here, we inoculated humanized NSG-SGM3 mice with Rift Valley fever virus (RVFV) to investigate...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2018-07, Vol.13 (7), p.e0201104-e0201104
Main Authors: Spengler, Jessica R, McElroy, Anita K, Harmon, Jessica R, Coleman-McCray, JoAnn D, Welch, Stephen R, Keck, James G, Nichol, Stuart T, Spiropoulou, Christina F
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rift Valley fever (RVF) in humans is usually mild, but, in a subset of cases, can progress to severe hepatic and neurological disease. Rodent models of RVF generally develop acute severe clinical disease. Here, we inoculated humanized NSG-SGM3 mice with Rift Valley fever virus (RVFV) to investigate whether the presence of human immune cells in mice would alter the progression of RVFV infection to more closely model human disease. Despite increased human cytokine expression, including responses mirroring those seen in human disease, and decreased hepatic viral RNA levels at terminal euthanasia, both high- and low-dose RVFV inoculation resulted in lethal disease in all mice with comparable time-to-death as unengrafted mice.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0201104